Tiangha, Eleutorio D.
HRN: 06-16-15 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/23/2023
CEFTAZIDIME 1GM (VIAL)
10/23/2023
10/30/2023
IV
1g
Q8H
CAP MR; PTB TALF
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes